$ICPT Recent Headlines U.S. stocks end lower; Dow turns

New Post Public Reply Private Reply Replies (0) Message Board

Aug 27, 2014 at 11:56 AM

$ICPT Recent Headlines

U.S. stocks end lower; Dow turns negative for the year 4:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 11:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 8:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 4:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 7:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 2:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 11:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 1:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 11:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 11:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 10:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 8:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 5:29 p.m. Jan. 10, 2014 - Sue Chang

Insider Buys And Sells- Priceline, Southern Copper Corp. 11:17 a.m. Aug. 26, 2014 - Seeking Alpha
3 Biotechs Surging Following InterMune Takeover - Analyst Blog 11:07 a.m. Aug. 26, 2014 - Zacks.com
Conatus Pharmaceuticals Down On Low Enthusiasm For High Risk 4:28 p.m. Aug. 25, 2014 - Seeking Alpha
InterMune Stock Spikes On Rare Big Biotech Buyout 10:40 a.m. Aug. 25, 2014 - Investors Business Daily
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/18/14 6:18 a.m. Aug. 19, 2014 - Seeking Alpha
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News 1:00 p.m. Aug. 14, 2014 - Zacks.com
Intercept Pharmaceuticals Inc Stock Upgraded (ICPT) 11:12 a.m. Aug. 14, 2014 - TheStreet.com
Perilous Reversal Watch: Intercept Pharmaceuticals (ICPT) 9:58 a.m. Aug. 14, 2014 - TheStreet.com
Analysts' Actions: Cree, Intercept Pharma, Intermune, Tivo 7:39 a.m. Aug. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog 10:40 a.m. Aug. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape 9:25 a.m. Aug. 13, 2014 - Zacks.com
'Fast Money' Recap: Stick With U.S. Stocks 5:00 a.m. Aug. 13, 2014 - TheStreet.com
U.S. Stocks End Lower 5:32 p.m. Aug. 12, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Russian Sanctions and Oil in Focus 8/12/14 - Stocks in the News 3:33 p.m. Aug. 12, 2014 - Zacks.com
Intercept Pharma (ICPT) Shares Soar on Liver Disease Drug News - Stocks in the News 2:40 p.m. Aug. 12, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Stock Is Skyrocketing Today 12:54 p.m. Aug. 12, 2014 - InvestorPlace.com
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Intercept Pharma Soars On Liver-Disease Drug Data 9:48 a.m. Aug. 12, 2014 - Investors Business Daily

Intercept to Present at Upcoming Investor Conferences 8:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 5:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 10:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 9:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 11:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 10:21 a.m. May 13, 2014 - ACCESSWIRE
Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week 4:06 p.m. May 6, 2014 - GlobeNewswire
Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences 6:06 a.m. May 1, 2014 - GlobeNewswire
Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer 4:50 p.m. April 30, 2014 - GlobeNewswire
Stock Price Movements, Updates on Clinical Studies, Financial Results Releases, and Company Response to New Laws - Analyst Notes on Perrigo, GlaxoSmithKline, Intercept, Centene and Lorillard 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- ICPT 4:01 a.m. April 14, 2014 - GlobeNewswire
Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session 12:00 p.m. April 12, 2014 - GlobeNewswire
Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis 9:04 a.m. April 11, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneAscent Welcomes Monica Stoudemire as New CCO

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Diaper Affordability: A Hidden Crisis, Taxpayer Burden

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Insurance Bad Faith: Navigating California's Rigorous Laws

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Deadline Looms for EquipmentShare Investors' Legal Action

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Veteran Marketer Joins The Wisory's Advisory Board

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

BusyBee AI Revolutionizes Classroom Feedback Efficiency

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...